CARRARO, ANNA
 Distribuzione geografica
Continente #
EU - Europa 378
NA - Nord America 258
AS - Asia 127
AF - Africa 5
SA - Sud America 5
OC - Oceania 1
Totale 774
Nazione #
IT - Italia 285
US - Stati Uniti d'America 255
SG - Singapore 84
SE - Svezia 23
ID - Indonesia 16
BG - Bulgaria 15
IN - India 14
IE - Irlanda 12
DE - Germania 11
CN - Cina 7
FR - Francia 7
FI - Finlandia 6
GB - Regno Unito 4
RO - Romania 4
MK - Macedonia 3
PH - Filippine 3
UA - Ucraina 3
BE - Belgio 2
BR - Brasile 2
CA - Canada 2
CO - Colombia 2
HK - Hong Kong 2
NG - Nigeria 2
TG - Togo 2
AL - Albania 1
AR - Argentina 1
AU - Australia 1
MA - Marocco 1
MX - Messico 1
NL - Olanda 1
PL - Polonia 1
TR - Turchia 1
Totale 774
Città #
Rome 89
Singapore 53
Milan 47
Chandler 28
Ashburn 27
Fairfield 27
New York 20
Jakarta 16
Sofia 15
Seattle 14
San Diego 12
Cambridge 9
Dublin 9
Palermo 9
Santa Clara 9
San Paolo di Civitate 8
Wilmington 8
Artena 7
Princeton 7
Lawrence 6
Naples 6
Woodbridge 6
Boardman 5
Helsinki 5
Pune 5
Ann Arbor 4
Colle Di Val D'elsa 4
Genoa 4
Munich 4
Sabaudia 4
Andover 3
Ascoli Piceno 3
Boston 3
Dasmariñas 3
Houston 3
Treviso 3
Abuja 2
Bogotá 2
Brussels 2
Cascina 2
Des Moines 2
Fuzhou 2
Hong Kong 2
Lomé 2
London 2
Millbury 2
Negrar 2
Rho 2
Sacramento 2
Spiegel 2
Toronto 2
Acton 1
Americana 1
Anandanagar 1
Baoding 1
Beijing 1
Bonndorf 1
Brescia 1
Bühl 1
Chieti 1
Civita Castellana 1
Federal 1
Fonte Nuova 1
Fremont 1
Groningen 1
Iesi 1
Kilburn 1
Lappeenranta 1
Los Angeles 1
Mannheim 1
Mexico City 1
Mondragone 1
Nanterre 1
Norwalk 1
Nuremberg 1
Orsay 1
Padova 1
Parma 1
Philadelphia 1
Piscataway 1
Prato 1
San Mateo 1
San Vittore Olona 1
Saviano 1
Seriate 1
Stockholm 1
Suyicun 1
Sydney 1
São Paulo 1
Trumbull 1
Vallefoglia 1
Verona 1
Warsaw 1
Totale 557
Nome #
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) 89
Increased sCD163 and sCD14 plasmatic levels and depletion of peripheral blood pro-inflammatory monocytes, myeloid and plasmacytoid dendritic cells in patients with severe COVID-19 pneumonia 74
Is albumin predictor of mortality in COVID-19 70
Real-life use of tocilizumab with or without corticosteroid in hospitalized patients with moderate-to-severe COVID-19 pneumonia. A retrospective cohort study 67
Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae prevention and control programme. Convergent or divergent action? 65
Use of remdesivir in patients with SARS-CoV-2 Pneumonia in a real-life setting during the second and third COVID-19 epidemic waves 55
Role of Tocilizumab in Down Regulating sCD163 Plasmatic Levels in a Cohort of COVID-19 Patients 49
Blood glucose and epicardial adipose tissue at the hospital admission as possible predictors for COVID-19 severity 47
Quality of t-cell response to SARS-CoV-2 mrrna vaccine in art-treated plwh 33
COVID-19 Severity and androgen receptor polymorphism 33
Post-infectious acute cerebellar ataxia treatment. A case report and review of literature 32
Longitudinal virological and immunological profile in a case of human monkeypox infection 31
A case of primary central nervous system lymphoma in advanced naive {HIV}-infected patient. The role of antiviral agents 30
Systemic, mucosal immune activation and psycho-sexual health in art-suppressed women living with HIV. Evaluating biomarkers and environmental stimuli 30
Immunogenicity and efficacy of vaccination in people living with human immunodeficiency virus 28
Effectiveness, Tolerability and Prescribing Choice of Antiviral Molecules Molnupiravir, Remdesivir and Nirmatrelvir/r: A Real-World Comparison in the First Ten Months of Use 28
Male reproductive health after 3 months from SARS-CoV-2 infection. A multicentric study 19
Longitudinal assessment of multiple immunological and inflammatory parameters during successful DAA therapy in HCV monoinfected and HIV/HCV coinfected subjects 14
Association Between NOX2-Mediated Oxidative Stress, Low-Grade Endotoxemia, Hypoalbuminemia, and Clotting Activation in COVID-19 13
Dysregulated inflammatory cytokine levels may be useful markers in a better up-dated management of COVID 19 10
null 9
Effectiveness, tolerability and prescribing choice of antiviral molecules molnupiravir, remdesivir and nirmatrelvir/r. A real-world comparison in the first ten months of use 8
null 3
Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians’ and nurses’ points of view 3
Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort 3
Totale 843
Categoria #
all - tutte 4.354
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.354


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 0 0 0 0 0 0 0 0 0 0 0 3
2020/202147 3 1 0 0 0 0 0 1 9 16 8 9
2021/2022146 7 6 19 6 10 18 22 5 10 7 24 12
2022/2023179 17 28 16 11 22 24 1 15 15 0 18 12
2023/2024313 13 12 9 24 32 67 15 9 1 69 33 29
2024/2025155 25 11 34 54 31 0 0 0 0 0 0 0
Totale 843